Cencora, Inc. reported $321.333B in FY2025 revenue and more than 51,000 employees in its latest annual filing. The company is led by Robert P. Mauch. Cencora is the renamed AmerisourceBergen platform, focused on pharmaceutical distribution and healthcare services.
How Cencora, Inc. Makes Money
Cencora earns revenue by distributing pharmaceuticals and healthcare products, supporting specialty providers, running international healthcare-solutions operations, and offering logistics and commercialization services to biopharma customers.
Latest Financial Snapshot
Fiscal 2025 revenue was $321.333B, up from $293.959B in fiscal 2024. Net income attributable to Cencora was $1.554B.
Why The Company Matters
The company's scale reflects decades of consolidation in U.S. pharmaceutical distribution, beginning with the 2001 Amerisource Health and Bergen Brunswig merger and continuing through international and specialty acquisitions.
